Alder BioPharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Alder BioPharmaceuticals, Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VYEPTI. The owner is based in Bothell, WA.
11804 North Creek Parkway South
Bothell, WA 98011
Showing of trademarks Trademarks
Trademark Classifications
Alder BioPharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Alder BioPharmaceuticals, Inc. have?
Alder BioPharmaceuticals, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 1 registered, 14 abandoned, 2 cancelled.
What trademark classes does Alder BioPharmaceuticals, Inc. file in?
Alder BioPharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Alder BioPharmaceuticals, Inc.'s most well-known trademarks?
Alder BioPharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as VYEPTI. These are among 1 currently registered trademark in the portfolio.
What is Alder BioPharmaceuticals, Inc.'s trademark registration success rate?
Alder BioPharmaceuticals, Inc. has a 6% trademark registration rate, with 1 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.